Marrone Bio Innovations Inc

NASDAQ:MBII  
1.17
+0.01 (+0.86%)
Earnings Announcements

Marrone Bio Innovations Reports Third-Quarter 2020 Financial Results

Published: 11/09/2020 22:48 GMT
Marrone Bio Innovations Inc (MBII) - Marrone Bio Innovations, Inc. Reports Third-quarter 2020 Financial Results.
Marrone Bio Innovations Inc Qtrly Revenues$8.8 Million Versus $7.0 Million.
Marrone Bio Innovations Inc Qtrly Basic and Diluted Net Loss per Common Share$0.04.
Revenue is expected to be $9.33 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $13.5 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.